David Van Sickle's eyes shine as he outlines the array of opportunities that have opened up ever since medical device maker ResMed acquired the Wisconsin startup in January 2019 for $225 million.
Digital therapeutics company Propeller will continue to operate as a standalone business within ResMed's Respiratory Care portfolio.
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
In a phone interview, Propeller Health CEO David Van Sickle and CTO Greg Tracy discussed how their digital therapeutics company has evolved since its founding in 2010.
The goal is to expand its connected device capabilities beyond asthma and COPD inhalers to include other diseases and drug delivery devices.